Ingevity
NGVT
307 hedge funds and large institutions have $2.56B invested in Ingevity in 2026 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 78 increasing their positions, 110 reducing their positions, and 37 closing their positions.
434% more call options, than puts
Call options by funds: $1.22M | Put options by funds: $228K
30% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 37
16% more capital invested
Capital invested by funds: $2.2B → $2.56B (+$355M)
1% more funds holding
Funds holding: 303 → 307 (+4)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
1.75% less ownership
Funds ownership: 103.56% → 101.8% (-1.8%)
29% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 110
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$38.1M |
| 2 |
Bessemer Group
Woodbridge,
New Jersey
|
+$17.7M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$16.2M |
| 4 |
Millennium Management
New York
|
+$15.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCOV
London Company of Virginia
Richmond,
Virginia
|
-$30.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$29.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$29M |
| 4 |
BlackRock
New York
|
-$20.7M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$16.4M |
NGVT Hedge Fund Activity: Q1 2026 in Review
307 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Ingevity (NGVT) for Q1 2026, worth a combined $2.56B — up 16% from $2.2B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new NGVT positions and 37 closed out — a net gain of 11 holders — while 78 added to existing stakes and 110 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $38.1M. The largest seller was London Company of Virginia, cutting an estimated $30.4M.
- 307 institutional investors held Ingevity (NGVT) as of Q1 2026, up from 303 in Q4 2025.
- Funds reported $2.56B of Ingevity stock for Q1 2026, up 16% quarter-over-quarter.
- 48 funds opened new Ingevity positions in Q1 2026 and 37 closed out, a net change of +11 holders.
- The largest Ingevity buyer in Q1 2026 was T. Rowe Price Associates, an estimated $38.1M added.
- The largest Ingevity seller in Q1 2026 was London Company of Virginia, an estimated $30.4M sold.
Based on aggregated 13F filings for Q1 2026.